Cargando…

Evaluation of Biomarkers for HER3-targeted Therapies in Cancer

Detalles Bibliográficos
Autores principales: Karachaliou, Niki, Rosell, Rafael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4484505/
https://www.ncbi.nlm.nih.gov/pubmed/26137561
http://dx.doi.org/10.1016/j.ebiom.2015.02.010
_version_ 1782378678954491904
author Karachaliou, Niki
Rosell, Rafael
author_facet Karachaliou, Niki
Rosell, Rafael
author_sort Karachaliou, Niki
collection PubMed
description
format Online
Article
Text
id pubmed-4484505
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-44845052015-07-01 Evaluation of Biomarkers for HER3-targeted Therapies in Cancer Karachaliou, Niki Rosell, Rafael EBioMedicine Commentary Elsevier 2015-02-16 /pmc/articles/PMC4484505/ /pubmed/26137561 http://dx.doi.org/10.1016/j.ebiom.2015.02.010 Text en © 2015 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Commentary
Karachaliou, Niki
Rosell, Rafael
Evaluation of Biomarkers for HER3-targeted Therapies in Cancer
title Evaluation of Biomarkers for HER3-targeted Therapies in Cancer
title_full Evaluation of Biomarkers for HER3-targeted Therapies in Cancer
title_fullStr Evaluation of Biomarkers for HER3-targeted Therapies in Cancer
title_full_unstemmed Evaluation of Biomarkers for HER3-targeted Therapies in Cancer
title_short Evaluation of Biomarkers for HER3-targeted Therapies in Cancer
title_sort evaluation of biomarkers for her3-targeted therapies in cancer
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4484505/
https://www.ncbi.nlm.nih.gov/pubmed/26137561
http://dx.doi.org/10.1016/j.ebiom.2015.02.010
work_keys_str_mv AT karachaliouniki evaluationofbiomarkersforher3targetedtherapiesincancer
AT rosellrafael evaluationofbiomarkersforher3targetedtherapiesincancer